(Q33634963)

English

Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

enzyme replacement therapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Barbara K Burton

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Nathalie Guffon

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jane Roberts

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ans T van der Ploeg

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Simon A Jones

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

HOS investigators

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

23 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

123-129

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Cumulative incidence rates of the mucopolysaccharidoses in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types II and VI, respectively

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Home treatment for Fabry disease: practice guidelines based on 3 years experience in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Intravenous enzyme replacement therapy: better in home or hospital?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

The frequency of lysosomal storage diseases in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Initial report from the Hunter Outcome Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.06.011

7 January 2021

Identifiers

10.1016/J.YMGME.2010.06.011

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33634963&oldid=1962149143"